Pvg Asset Management Corp Checkpoint Therapeutics, Inc. Transaction History

Pvg Asset Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.52 - $11.2 $204,035 - $4.39 Million	-392,375 Closed	0 $0
Q3 2022 Oct 13, 2022	BUY	$1.02 - $10.6 $318,309 - $3.31 Million	312,068 Added 388.59%	392,375 $0
Q4 2021 Feb 02, 2022	SELL	$2.68 - $4.46 $23,637 - $39,337	-8,820 Reduced 9.9%	80,307 $249,000
Q3 2021 Nov 10, 2021	BUY	$2.5 - $3.53 $160,050 - $225,990	64,020 Added 254.99%	89,127 $294,000
Q2 2021 Aug 17, 2021	BUY	$2.36 - $3.2 $24,166 - $32,768	10,240 Added 68.88%	25,107 $74,000
Q1 2021 May 14, 2021	BUY	$2.6 - $4.16 $38,654 - $61,846	14,867 New	14,867 $46,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $302M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Pvg Asset Management Corp with notifications on news.